LBF20207PG29: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 6: | Line 6: | ||
|LipidBank=XPR1713 | |LipidBank=XPR1713 | ||
|LipidMaps=LMFA03010024 | |LipidMaps=LMFA03010024 | ||
|SysName=9-Oxo-11alpha,15S,19R-trihydroxy-prosta- | |SysName=9-Oxo- (11alpha,15S,19R) -trihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid | ||
|Common Name=&&19(R) -hydroxy Prostaglandin E_2&& | |Common Name=&&19(R) -hydroxy Prostaglandin E_2&&9-Oxo- (11alpha,15S,19R) -trihydroxy-prosta- (5Z,13E) -dien-1-oic acid | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= |
Latest revision as of 08:31, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1713 |
LipidMaps | LMFA03010024 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG29 |
19(R) -hydroxy Prostaglandin E2 | |
---|---|
Structural Information | |
9-Oxo- (11α,15S,19R) -trihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
Formula | C20H32O6 |
Exact Mass | 368.219888756 |
Average Mass | 368.46448 |
SMILES | [C@H]([C@@H](C=C[C@H](O)CCC[C@@H](C)O)1)(C(C[C@H]1O)=O)CC=CCCCC(O)=O |
Physicochemical Information | |
19(R)-hydroxy PGE2 is a potent smooth muscle relaxant and a selective agonist for the EP2 receptor. Kelly_RW et al. Woodward_DF et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|